KMICB - Lipid Management
Kent and Medway Guidance
Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD
K&M Implementation Guidance for NICE TA 694: Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia
K&M ICB Position Statement: Prescribing Inclisiran (Leqvio®) for the treatment of primary hypercholesterolaemia or mixed dyslipidaemia
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary